AU2000252449A1 - Recombinant vaccines against infectious bursal disease virus - Google Patents

Recombinant vaccines against infectious bursal disease virus

Info

Publication number
AU2000252449A1
AU2000252449A1 AU2000252449A AU5244900A AU2000252449A1 AU 2000252449 A1 AU2000252449 A1 AU 2000252449A1 AU 2000252449 A AU2000252449 A AU 2000252449A AU 5244900 A AU5244900 A AU 5244900A AU 2000252449 A1 AU2000252449 A1 AU 2000252449A1
Authority
AU
Australia
Prior art keywords
disease virus
vaccines against
bursal disease
infectious bursal
against infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000252449A
Other languages
English (en)
Inventor
Orit Edelbaum
Tanya Gontmakher
Eli Khayat
Arie Rogel
Ilan Sela
Yehoshua Shachar
Yehuda Stram
Yehuda Zanberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rahan Meristem Ltd
Original Assignee
Rahan Meristem Ltd
Meristem Rahan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rahan Meristem Ltd, Meristem Rahan filed Critical Rahan Meristem Ltd
Publication of AU2000252449A1 publication Critical patent/AU2000252449A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU2000252449A 2000-06-19 2000-06-19 Recombinant vaccines against infectious bursal disease virus Abandoned AU2000252449A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2000/000360 WO2001097839A1 (en) 2000-06-19 2000-06-19 Recombinant vaccines against infectious bursal disease virus

Publications (1)

Publication Number Publication Date
AU2000252449A1 true AU2000252449A1 (en) 2002-01-02

Family

ID=11042982

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000252449A Abandoned AU2000252449A1 (en) 2000-06-19 2000-06-19 Recombinant vaccines against infectious bursal disease virus

Country Status (3)

Country Link
EP (1) EP1296710A4 (de)
AU (1) AU2000252449A1 (de)
WO (1) WO2001097839A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368602B1 (en) * 2000-06-16 2002-04-09 Hadasit Medical Research Services And Development Ltd Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
CN112442131B (zh) * 2019-08-28 2022-08-12 中国农业科学院生物技术研究所 基于自组装铁蛋白纳米抗原颗粒及由其制备的传染性法氏囊病疫苗和应用
WO2023227599A1 (en) 2022-05-23 2023-11-30 Atlantic Technological University Antimicrobial coating composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222842B1 (de) * 1985-05-30 1995-05-10 Commonwealth Scientific And Industrial Research Organisation Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv)
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5641490A (en) * 1991-03-07 1997-06-24 Virogenetics Corporation Infectious bursal disease virus recombinant poxvirus vaccine
US5605792A (en) * 1993-11-04 1997-02-25 The Ohio State University Research Foundation Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon

Also Published As

Publication number Publication date
EP1296710A4 (de) 2004-05-12
WO2001097839A1 (en) 2001-12-27
EP1296710A1 (de) 2003-04-02

Similar Documents

Publication Publication Date Title
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU5562798A (en) Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus.
GB2337755B (en) Virus vaccine
DE60219865D1 (de) Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
AU6029000A (en) Mosaic infectious bursal disease virus vaccines
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
EP1399481A4 (de) Rekombinante antikörper gegen infectious bursal disease virus (ibdv)
AU2001271976A1 (en) Microspheres and adjuvants for dna vaccine delivery
AU2002307971A1 (en) Vaccine against the nile fever virus
EP1749885B8 (de) Impfstoff von infektiösen und attenuierten Rinderdiarrhoeviren
DK1372712T3 (da) Vaccine mod equint herpesvirus
AU2000252449A1 (en) Recombinant vaccines against infectious bursal disease virus
AU2001278337A1 (en) Respiratory syncytial virus vaccine
IL177903A (en) Vaccine for Infectious Stock Disease Virus and its Use
DK1248650T3 (da) Forbedrede DNA-vacciner til bovint herpesvirus 1
AU2003227026A1 (en) An infectious bursal disease virus variant
AU2002310654A1 (en) Bursal disease virus-like particles
AU5098700A (en) Dna vaccine for protecting an avian against infectious bursal disease virus
AU2002243257A1 (en) Oncolytic virus
AU1674200A (en) Dna vaccine against infectious bursal disease virus
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
GB0001475D0 (en) Virus strains
HUP0102823A3 (en) A broad spectrum infectious bursal disease virus vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 44283/00, 52200/00, 52447/00, 52449/00, 70400/00, 75633/00, 58199/01, 60313/01, 60450/01, 60720/01, 60775/01, 62457/01, 62561/01, 62888/01, 63999/01, 64000/01, 64339/01, 64348/01, 64356/01, 64382/01, 65672/01, 65673/01, 65675/01, 65676/01, 65679/01, 65681/01, 65687/01, 65689/01, 65693/01, 65694/01, 65695/01, 65697/01, 65698/01, 65699/01, 65700/01, 65701/01, 65705/01, 65709/01, 74016/01